Dermatology Flashcards
Pemphigoid vs Pemphigus
PemphiguS
Superficial (sub-epidermal) - within the epidermis
Nikolsky positive
Younger
PemphigoiD
Deep (intra-epidermal) - junction between epidermis and dermis
Nikolsky negative
Older
Treat with steroids
Bowen’s Disease
Epidemiology
Also known as intraepidermal SCC.
Skin type 1/2, aged ~60 years
Aetiology
Long-term sun exposure
Mutant p53 resulting in uncontrolled skin cell growth
Increased risk in immunosuppressed individuals
Clinical Features
Red scaly patch on shin
Investigations
Clinical examination
Histological dx - excision/punch/incisional biopsy
Management
Watchful waiting
Topical flurouracil (large/multiple)
Curettage and excision (small/single)
Topical Imquimod
Psoariasis
Epidemiology
Peak onset 15-25 and 50-60 years
Chronic plaque psoriasis is commonest form
Aetiology
Immune-mediated inflammatory disease
Risk Factors:
Drugs: B-blockers, Anti-malarials, Lithium, Indomethacin/NSAIDs (BALI)
Skin trauma (Koebner phenomenon)
Infection: Streptococcus, HIV
Drugs: B-blockers, Anti-malarials, Lithium, Indomethacin/NSAIDs (BALI)
Withdrawal of steroids
Stress
Alcohol + smoking
Cold/dry weather
Clinical Features
Pruritic symmetrical red, scaly plaques with well-defined edges (may appear shiny and moist on flexural surfaces)
Nail pitting and onycholysis (nailbed separation)
Affects scalp and extensors (elbows and knees)
Investigations
Skin Biopsy findings include epidermal thickening, munro microabscesses (leucocytes)
Absence of bacteria (normal pilosebaceous units)
Management
Topical Treatment
All patients should use an emollient to reduce scale and itch
1st: potent topical corticosteroid OD (eg Betnovate) + topical vitamin D OD (eg Dovonex) applied at different times
2nd: stop the topical corticosteroid, apply topical vitamin D twice daily
3rd: stop the topical vitamin D, apply potent topical corticosteroid twice daily
Dithranol + tar are alternatives
Phototherapy
1st: narrowband UVB phototherapy
2nd: psoralen + UVA (PUVA)
Systemic treatment
1st: methotrexate
2nd: ciclosporin (1st line if rapid disease control needed/palmoplantar pustulosis/are considering conception)
3rd: acitretin
Biological treatment
Infliximab
Etanercept
Adalimumab
Topical Steroid potencies
Topical steroid potencies
Topical corticosteroids are available in 4 different potencies (remembered by the mnemonic “Help Every Budding Dermatologist”)
Mild- Hydrocortisone 0.5%
Moderate- Eumovate (clobetasone butyrate 0.05%)
Potent- Betnovate (betamethasone valerate 0.1%)
Very potent- Dermovate (clobetasol propionate 0.05%)
Topical steroid guiding points
Potent/very potent topical corticosteroids should not be used on the face or genitals.
Very potent topical corticosteroids should not be used in primary care, but should only be prescribed by dermatologists.
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management
Condition
Epidemiology
Aetiology
Clinical Features
Investigations
Management